Cannabidiol – March 2026

Oral liquid 100 mg per mL, 100 mL

  • Brand names:
    • Epidyolex®
  • Pharmaceutical Company:
    • JAZZ PHARMACEUTICALS ANZ PTY LTD
  • Condition/Indication: Severe myoclonic epilepsy in infancy (Dravet syndrome)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026